Tremfya (generic name: guselkumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults. It belongs to a class of medications called interleukin inhibitors, specifically targeting interleukin-23 (IL-23), which plays a role in the development of psoriasis.
Dosage and Administration:
Tremfya is available as a pre-filled syringe (PFS) containing 100 mg of guselkumab. The recommended dosage for Tremfya is 100 mg injected subcutaneously (under the skin) at weeks 0 and 4, followed by maintenance doses of 100 mg every 8 weeks.
Usage:
Tremfya is administered by subcutaneous injection. Here are the general steps for using Tremfya:
Prepare: Wash your hands thoroughly with soap and water. Remove the Tremfya pre-filled syringe from the refrigerator and allow it to reach room temperature for about 30 minutes. Do not shake the syringe.
Choose an injection site: Common injection sites include the front of the thighs, lower abdomen (at least 2 inches away from the navel), or upper arm (if someone else is administering the injection). Rotate injection sites to minimize the risk of skin reactions.
Cleanse the injection site: Use an alcohol swab to clean the chosen injection site and let it dry.
Inject the medication: Remove the cap from the Tremfya pre-filled syringe. Pinch a fold of skin at the cleaned injection site and insert the needle into the skin at a 45-degree angle. Slowly push the plunger down to inject the full dose. Once the injection is complete, remove the syringe and dispose of it safely according to medical waste disposal guidelines.
Monitor for any adverse reactions: It is normal to experience mild injection site reactions, such as redness, itching, or pain. However, if you notice any severe or persistent reactions, contact your healthcare provider.
It is important to follow the dosage schedule and administration instructions provided by your healthcare provider. If you have any questions or concerns about the administration of Tremfya, consult with your healthcare provider or a healthcare professional.
Precautions:
Before using Tremfya, inform your healthcare provider about any medical conditions you have, including infections, immunodeficiency disorders, or allergies. Also, disclose all medications you are currently taking, as certain drugs may interact with Tremfya.
During treatment with Tremfya, it is recommended to follow up regularly with your healthcare provider to monitor your response to the medication and assess for any potential side effects.
In summary, Tremfya (guselkumab) is a medication used to treat moderate to severe plaque psoriasis. It is administered through subcutaneous injections of 100 mg at weeks 0 and 4, followed by maintenance doses every 8 weeks. Follow the provided instructions and consult your healthcare provider for any specific concerns or questions about using Tremfya.